Literature DB >> 17555851

Pre- or post-pandemic influenza vaccine?

Albert D M E Osterhaus.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17555851     DOI： 10.1016/j.vaccine.2007.05.033

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  9 in total

1.  Experimental vaccines against potentially pandemic and highly pathogenic avian influenza viruses.

Authors:  Alaina J Mooney; S Mark Tompkins
Journal:  Future Virol       Date:  2013-01-01       Impact factor: 1.831

2.  Strategies for mitigating an influenza pandemic with pre-pandemic H5N1 vaccines.

Authors:  George Milne; Joel Kelso; Heath Kelly
Journal:  J R Soc Interface       Date:  2009-09-15       Impact factor: 4.118

Review 3.  Development of stable influenza vaccine powder formulations: challenges and possibilities.

Authors:  J-P Amorij; A Huckriede; J Wilschut; H W Frijlink; W L J Hinrichs
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

4.  An oil-in-water nanoemulsion enhances immunogenicity of H5N1 vaccine in mice.

Authors:  Weiping Cao; William G Davis; Jin Hyang Kim; Juan A De La Cruz; Andrew Taylor; Grant R Hendrickson; Amrita Kumar; Priya Ranjan; L Andrew Lyon; Jacqueline M Katz; Shivaprakash Gangappa; Suryaprakash Sambhara
Journal:  Nanomedicine       Date:  2016-04-23       Impact factor: 5.307

5.  A phase II, open-label, multicentre study to evaluate the immunogenicity and safety of an adjuvanted prepandemic (H5N1) influenza vaccine in healthy Japanese adults.

Authors:  Hideaki Nagai; Hideyuki Ikematsu; Kazuyoshi Tenjinbaru; Atsushi Maeda; Mamadou Dramé; François P Roman
Journal:  BMC Infect Dis       Date:  2010-11-25       Impact factor: 3.090

6.  Dose-sparing H5N1 A/Indonesia/05/2005 pre-pandemic influenza vaccine in adults and elderly adults: a phase III, placebo-controlled, randomized study.

Authors:  Joanne M Langley; George Risi; Michael Caldwell; Larry Gilderman; Bruce Berwald; Charles Fogarty; Terry Poling; Dennis Riff; Mira Baron; Louise Frenette; Eric Sheldon; Harry Collins; Marc Shepard; Marc Dionne; Daniel Brune; Linda Ferguson; David Vaughn; Ping Li; Louis Fries
Journal:  J Infect Dis       Date:  2011-06-15       Impact factor: 5.226

7.  Age-prioritized use of antivirals during an influenza pandemic.

Authors:  Stefano Merler; Marco Ajelli; Caterina Rizzo
Journal:  BMC Infect Dis       Date:  2009-07-28       Impact factor: 3.090

8.  Comparing Deaths from Influenza H1N1 and Seasonal Influenza A: Main Sociodemographic and Clinical Differences between the Most Prevalent 2009 Viruses.

Authors:  German Fajardo-Dolci; Juan Pablo Gutierrez; Heberto Arboleya-Casanova; Sebastian Garcia-Saiso
Journal:  Influenza Res Treat       Date:  2012-12-30

Review 9.  A vaccine manufacturer's approach to address medical needs related to seasonal and pandemic influenza viruses.

Authors:  Benoit Baras; Nancy Bouveret; Jeanne-Marie Devaster; Louis Fries; Paul Gillard; Roland Sänger; Emmanuel Hanon
Journal:  Influenza Other Respir Viruses       Date:  2008-11       Impact factor: 4.380
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.